Newsletter | May 20, 2020

05.20.20 -- Pfizer Shifts Outsourcing And Communication To Fight COVID-19

 
Sponsor
From The Editor
Featured Editorial
Industry Insights
Is Not Using A CDMO Slowing Down Your Process Development?

Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful but also improve your chances of getting to market sooner.

A Bridge Over Troubled Water: The Journey To Serialization Compliance

This regulation from the FDA outlined serialization and traceability requirements spread over the course of 10 years with, preparation for each phase accumulating into a potentially high overall price tag.

Next-Gen Bioinformatics: The Expanding Role Of Deep-Learning Algorithms

Deep-learning algorithms have shown significant promise as applications in natural language understanding, decision making, and speech and image recognition. These algorithms are now being applied in bioinformatics applications within the biopharma industry to manage the increasing amounts of data from high-throughput techniques. Read more about recent applications of these algorithms to predict a variety of biological processes and interactions, particularly with respect to proteins.

Answering Today’s Pharma Dilemma Of Build Or Buy

A new business and operating model may address the build or buy dilemma, offering an innovative and agile way to manage demand uncertainty and reduce the risks associated with early investment decisions.

Guide Clients Through Drug Development With Intelligent Collaboration

This article is a recent discussion with the general manager of Pfizer CentreOne regarding what it’s like to lead an embedded CDMO within one of the largest pharmaceutical companies.

An Engineered Platform For High-Loaded Dosage Forms Of Amorphous Solid Dispersions

This poster outlines a novel engineered platform for the formulation of high-active-loading oral solid dosage forms containing amorphous solid dispersions (ASDs) of a rapidly crystallizing drug with a low glass-transition temperature (Tg).

uFlux In Vitro/In Vivo Correlation (IVIVC) Testing Trans-Membrane Permeation And BSC Class II Formulation Challenges

This poster focuses on methods that could discriminate against formulation differences that may not present using traditional in vitro dissolution techniques.

Create Brand Sustainability With Softgel Technology

Keeping an eye on some emerging trends that are shaping society and the pharmaceutical industry can help you meet diverse consumer preferences and potentially extend product life cycles.

Are You Protecting Your Employees During HPAPI Manufacturing?

As biomanufacturers venture into the rapidly growing market of high potency APIs (HPAPIs) it is important to consider whether they have the resources and capabilities to protect their product and their employees.

Solutions
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.